Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia
Clinical trial NCT01391403 · COMPLETED
Trial details
- NCT number
- NCT01391403
- Sponsor
- Beijing HuiLongGuan Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-04-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.